ecancer

Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma

Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA

21 Oct 2018

Editor's Choice for June 2018

Prof Gordon McVie - Founding Editor, ecancer

4 Jul 2018

EHA 2018: The unmet needs in maintenance therapy for multiple myeloma

Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng

15 Jun 2018

Updates in melanoma from ASCO 2018

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands

4 Jun 2018

Editor’s Choice for May 2018

Prof Gordon McVie - Founding Editor, ecancer

21 May 2018

Reducing recurrence of advanced melanoma with pembrolizumab

Prof Alex Eggermont - Paris-Sud University, Paris, France

25 Apr 2018

Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.

Prof Alex Eggermont - Paris-Sud University, Paris, France

25 Apr 2018

Lenalidomide with rituximab for mantle cell lymphoma

Prof Jia Ruan - Weill Cornell Medicine and New York Presbyterian Hospital, New York, USA

11 Dec 2017

A biological perspective for personalising immunotherapies

Dr Tom Lillie - Head of European Clinical Development, MSD, London, UK

6 Dec 2017

Editor's Choice for November 2017

Prof Gordon McVie - Founding Editor, ecancer

4 Dec 2017

The promise of immunotherapy for elderly patients

Dr Alistair Greystoke - Newcastle University, Newcastle, UK

15 Nov 2017

Adoptive cell therapy for solid tumours

Dr Sophie Papa - Guy's Hospital, London, UK

18 Oct 2017

More from ecancer